SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950162-08-000097
Filing Date
2008-02-13
Accepted
2008-02-13 15:34:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA INC. - SIGMA TAU PHARMACEUTICALS SCHEDULE 13G/A NO. 1 dorsigtaupharm13gano1_021308.htm SC 13G/A 227514
  Complete submission text file 0000950162-08-000097.txt   229675
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39976 | Film No.: 08604332
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877
Business Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877 1-800-447-0169
Sigma-Tau Pharmaceuticals, Inc. (Filed by) CIK: 0001385625 (see all company filings)

IRS No.: 953566292 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G/A